Bage - A New Gene Encoding An Antigen Recognized On Human Melanomas By Cytolytic T-Lymphocytes

[en] Several tumor antigens are recognized by autologous cytolytic T lymphocytes (CTL) on human melanoma MZ2-MEL. Some of them are encoded by genes MAGE-1 and MAGE-3, which are not expressed in normal tissues except in testis. Here, we report the identification of a new gene that codes for another of these antigens. This gene, named BAGE, codes for a putative protein of 43 aa and seems to belong to a family of several genes. The antigen recognized by the autologous CTL consists of BAGE-encoded peptide AARAVFLAL bound to an HLA-Cw 1601 molecule. Gene BAGE is expressed in 22% of melanomas, 30% of infiltrating bladder carcinomas, 10% of mammary carcinomas, 8% of head and neck squamous cell carcinomas, and 6% of non-small cell lung carcinomas. Like the MAGE genes, it is silent in normal tissues with the exception of testis. Because of its tumor-specific expression, the BAGE-encoded antigen may prove useful for cancer immunotherapy.

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

Boel, P.

Wildmann, C.

Sensi, Ml.

Brasseur, Robert ; Université de Liège - ULiège > Gembloux Agro-Bio Tech

Renauld, Jc.

Coulie, P.

Boon, T.

Vanderbruggen, P.

Language :

English

Title :

Bage - A New Gene Encoding An Antigen Recognized On Human Melanomas By Cytolytic T-Lymphocytes

Publication date :

1995

Journal title :

Immunity

ISSN :

1074-7613

eISSN :

1097-4180

Publisher :

Cell Press, United States - Massachusetts

Volume :

Issue :

Pages :

167-175
167-75

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 25 June 2010

Statistics

Number of views

43 (7 by ULiège)

Number of downloads

5 (5 by ULiège)

More statistics

Scopus citations^®

570

Scopus citations^®
without self-citations

513

OpenCitations

407

OpenAlex citations

598

Bibliography

Atherton, Logan, Sheppard (1981) Peptide synthesis II Procedures for solid phase synthesis using Nα-fluorenylmethoxycarbamylamino-acid on polymide supports synthesis of substance P and of acyl carrier protein 65–74 decapeptide. Journal of the Chemical Society, Perkin Transactions 1 1:538-546.
Bakker, Schreurs, de Boer, Kawakami, Rosenberg, Adema, Figdor (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. Journal of Experimental Medicine 179:1005-1009.
Boon, Cerottini, Van den Eynde, van der Bruggen, Van Pel (1994) Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
Boon, Van Snick, Van Pel, Uyttenhove, Marchand (1980) Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte—mediated cytolysis. J. Exp. Med. 152:1184-1193.
Brichard, Van Pel, Wölfel, Wölfel, De Plaen, Lethé, Coulie, Boon (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
Chomczynski, Sacchi (1987) Single-step method of RNA isolation by acid guanidium thiocyanate—phenol—chloroform extraction. Annal Biochem 162:156-159.
Coulie, Brichard, Van Pel, Wölfel, Schneider, Traversari, De Plaen, Lurquin, Szikora, Renauld, Boon (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
Cox, Skipper, Chen, Henderson, Darrow, Shabanowitz, Engelhard, Hunt, Slingluff (1994) Identification of a peptide recognized by five melanomaspecific human cytotoxic T cell lines. Science 264:716-719.
Davis, Dibner, Battey Basic Methods in Molecular Biology , Elsevier, New York; 1986, 130-135.
De Plaen, Arden, Traversari, Gaforio, Szikora, De Smet, Brasseur, van der Bruggen, Lethé, Lurquin, Brasseur, Chomez, De Backer, Cavenee, Boon (1994) Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 40:360-369.
De Smet, Lurquin, van der Bruggen, De Plaen, Brasseur, Boon (1994) Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 39:121-129.
Espevik, Nissen-Meyer (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Meth. 95:99-105.
Gaugler, Van den Eynde, van der Bruggen, Romero, Gaforio, De Plaen, Lethé, Brasseur, Boon (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
Genevee, Diu, Nierat, Caignard, Dietrich, Ferradini, Roman-Roman, Triebel, Hercend (1992) An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261-1269.
Haas, D'Cruz, De Bault (1988) Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am. J. Reprod. Immunol. Microbiol. 18:47-51.
Hansen, Nielsen, Berg (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth. 119:203-210.
Hérin, Lemoine, Weynants, Vessiere, Van Pel, Knuth, Devos, Boon (1987) Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer 39:390-396.
Horth, Lambrecht, Chuah Lay Khim, Bex, Thiriart, Ruysschaert, Burny, Brasseur (1991) Theoretical and functional analysis of the SIV fusion peptide. EMBO J. 10:2747-2755.
Kawakami, Eliyahu, Delgado, Robbins, Rivoltini, Topalian, Miki, Rosenberg (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515-3519.
Mostofi, Sobin, Torlini (1973) Histological typing of urinary bladder tumors. WHO International Histological Classification of Tumors, WHO, New York; .
Neefjes, Ploegh (1988) Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with β2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur. J. Immunol. 18:801-810.
Nicolas, Berg (1983) Regulation of expression of genes transduced into embryonal carcinoma cells. Cold Spring Harbor Conferences Cell Prolif. 10:469-485.
Padovan, Casorati, Dellabona, Meyer, Brockhaus, Lanzavecchia (1993) Expression of two T cell receptor alpha chains: dual receptor T cells. Science 262:422-424.
Patard, Brasseur, Gil-Diez, Radvanyi, Marchand, François, Abi Aad, Van Cangh, Abbou, Chopin, Boon (1995) Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer, in press; .
Robbins, El-Gamil, Kawakami, Rosenberg (1994) Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124-3126.
Seed, Aruffo (1987) Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA 84:3365-3369.
Takebe, Seiki, Fujisawa, Hoy, Yokota, Arai, Yoshida, Arai (1988) SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466-472.
Traversari, van der Bruggen, Luescher, Lurquin, Chomez, Van Pel, De Plaen, Amar-Costesec, Boon (1992) A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176:1453-1457.
Traversari, van der Bruggen, Van den Eynde, Hainaut, Lemoine, Ohta, Old, Boon (1992) Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35:145-152.
Van den Eynde, Hainaut, Hérin, Knuth, Lemoine, Weynants, van der Bruggen, Fauchet, Boon (1989) Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer 44:634-640.
Van den Eynde, Lethé, Van Pel, De Plaen, Boon (1991) The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173:1373-1384.
van der Bruggen, Traversari, Chomez, Lurquin, De Plaen, Van den Eynde, Knuth, Boon (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-1647.
van der Bruggen, Bastin, Gajewski, Coulie, Boël, De Smet, Traversari, Townsend, Boon (1994) A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24:3038-3043.
van der Bruggen, Szikora, Boël, Wildmann, Somville, Sensi, Boon (1994) Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol. 24:2134-2140.
Van Pel, De Plaen, Boon (1985) Selection of a highly transfectable variant from mouse mastocytoma P815. Som. Cell Genet. 11:467-475.
Vonèche, Protetelle, Kettmann, Willems, Limbach, Paoletti, Ruysschaert, Burny, Brasseur (1992) Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proceedings of the National Academy of Sciences 89:3810-3814.
Wölfel, Van Pel, Brichard, Schneider, Seliger, Meyer zum Büschenfelde, Boon (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24:759-764.